How Much Baclofen Can You Take in a Day?

The standard maximum daily dose of oral baclofen approved for spasticity is 80 mg, split into three doses throughout the day. Most adults start at just 15 mg per day and work up slowly from there. That ceiling, though, is not the whole story. Off-label prescribing for alcohol use disorder sometimes pushes well above 80 mg, intrathecal pump delivery uses doses measured in micrograms rather than milligrams, and kidney problems can make even a modest dose dangerous.

Standard Oral Dosing for Spasticity

Baclofen’s FDA-approved use is to treat muscle spasticity from conditions like multiple sclerosis, spinal cord injury, and cerebral palsy. The typical starting dose for adults is 5 mg taken three times a day. From there, your prescriber increases each individual dose by 5 mg every three days until the spasticity improves or side effects become bothersome. The labeled ceiling is 80 mg per day, usually divided into three or four doses.

Immediate-release baclofen has a short half-life, which is why it needs to be taken multiple times a day. That frequent dosing schedule is one of the drug’s biggest practical drawbacks. Drowsiness, dizziness, and muscle weakness tend to be the first side effects people notice, and they often track with each new dose increase. For many patients, the effective daily dose lands somewhere between 40 and 60 mg. Reaching the full 80 mg is less common because side effects often limit the climb.

Modified-release formulations have been developed to allow once-daily or twice-daily dosing at the same total daily amount. Early research on sustained-release and gastric-retentive versions showed they could deliver comparable drug exposure with a smoother absorption curve, which reduced the peak-related side effects like sudden drowsiness and drops in blood pressure that come with immediate-release tablets.¹ Floating bead formulations tested in animals confirmed that blunting the sharp plasma peak lowered the hypotensive side effect associated with rapid absorption.² The underlying challenge is that baclofen is absorbed mainly in the upper gut, so getting a tablet to stay there long enough for slow release is an active area of pharmaceutical research.³

How Kidney Function Changes the Safe Dose

Baclofen is cleared primarily through the kidneys. About three quarters of an oral dose is absorbed into the bloodstream, and the body depends on healthy kidney filtration to get rid of it.⁴ When kidney function declines, baclofen hangs around longer and builds up to higher levels than intended. That buildup can cause toxicity even at doses that would be safe for someone with normal kidneys.

A pharmacokinetic study of baclofen in patients with varying degrees of kidney disease found that the drug’s clearance dropped in lockstep with kidney function. The researchers proposed straightforward dose cuts: roughly one-third reduction for mild kidney disease, half for moderate, and two-thirds for severe.⁵ A separate review went further and recommended avoiding baclofen altogether in people with severely reduced kidney function or those on dialysis, because the risk of toxicity becomes difficult to manage.⁶

This is not a theoretical concern. Published case reports of baclofen toxicity disproportionately involve patients whose kidney function was either unrecognized as impaired or deteriorated after the drug was prescribed. If you have any degree of kidney disease, even a mild reduction in function, your prescriber should be adjusting the daily dose downward rather than following the standard titration schedule.

Off-Label Dosing for Alcohol Use Disorder

Baclofen has attracted considerable attention as a treatment for alcohol dependence, and this is where daily doses can climb far above the 80 mg spasticity ceiling. In clinical trials, most studies used fixed doses in the range of 30 to 80 mg per day, but several trials allowed individualized dose escalation and saw maintenance doses ranging from 30 to well over 300 mg per day.⁷ One randomized trial that allowed doses up to 270 mg per day reported that participants averaged 180 mg daily.⁸

The effectiveness of these higher doses remains contested. A large multicenter trial found that neither low-dose nor high-dose baclofen outperformed placebo for alcohol dependence, and adverse events like fatigue, sleepiness, and dry mouth were frequent and dose-related. One serious adverse event was attributed to the high-dose group.⁹ A meta-analysis echoed this: tolerability of high-dose baclofen was low, though serious adverse events remained rare.¹⁰ A more recent dose-response meta-analysis found that doses above 60 mg per day could not be reliably evaluated because of limited data and differences between the studies that used them.¹¹

In France, regulatory authorities temporarily approved baclofen at doses up to 300 mg per day for alcohol dependence before later pulling back. The takeaway for patients is that high-dose baclofen for alcohol use is experimental territory, and anyone taking more than 80 mg daily needs close medical supervision and should understand that the evidence base is thinner than it might sound.

Intrathecal Baclofen Is a Completely Different Dosing World

When oral baclofen does not control spasticity well enough, or its side effects are intolerable, a surgically implanted pump can deliver the drug directly into the fluid surrounding the spinal cord. Because intrathecal delivery bypasses the blood-brain barrier, far less drug is needed. The dose required can be as much as a thousand times smaller than the equivalent oral dose.¹²

In a matched comparison study, patients on intrathecal baclofen averaged about 577 micrograms per day, while those on oral baclofen averaged about 86 mg per day.¹³ To put that in perspective, 577 micrograms is less than 0.6 milligrams. Dosing adjustments for intrathecal baclofen follow strict protocols: increases of 5 to 15 percent every 24 hours for spasticity of cerebral origin, and 10 to 30 percent for spinal-origin spasticity, with assessment required within a day of each change.¹⁴

Intrathecal delivery also carries a unique risk: if the pump malfunctions, runs dry, or the catheter kinks, the abrupt loss of baclofen can trigger a life-threatening withdrawal syndrome. This syndrome, which evolves over one to three days, features high fever, altered mental status, and extreme muscle rigidity that can progress to rhabdomyolysis and death if not treated quickly. The immediate fix is restoring baclofen delivery; in the meantime, high-dose benzodiazepines can bridge the gap.¹⁵

Overdose and Where Toxicity Begins

Baclofen overdose is a medical emergency. A review of poisoning cases found that the mean ingested dose in overdose was around 630 mg, with a range from 80 mg to 2,500 mg. Coma, delirium, and seizures appeared only in patients who ingested 200 mg or more, and those patients had higher rates of ICU admission and mechanical ventilation.¹⁶

A larger systematic review confirmed this pattern: baclofen toxicity commonly presented with central nervous system depression in about two-thirds of cases, seizures in about a third, and respiratory depression in roughly one in five, with these severe effects concentrated at doses of 300 mg or more.¹⁷ There is no specific antidote. Treatment is supportive, meaning the medical team focuses on keeping you breathing, managing seizures, and monitoring organ function while the drug clears your system.¹⁸

The practical message: a dose of 200 mg or more in someone without tolerance is dangerous territory, and doses above 300 mg carry a high likelihood of life-threatening complications. In people with impaired kidneys, toxicity can occur at much lower doses because the drug accumulates. Anyone taking baclofen should know that doubling up on a missed dose is a bad idea, and that keeping tablets secure from children or others in the household is important given how quickly the drug can cause severe sedation.

Tolerance and Why Doses Sometimes Need to Go Up

Baclofen works by activating GABA-B receptors in the brain and spinal cord. Over time, the body can adapt. Animal studies show that chronic baclofen exposure leads to a measurable decrease in the density of GABA-B receptors. In rats receiving intrathecal baclofen, receptor binding in the spinal cord dropped to about two-thirds of normal after seven days, and this receptor loss correlated with the animals regaining motor function despite the ongoing drug infusion.¹⁹

A separate study found that chronic baclofen treatment significantly reduced GABA-B-mediated signaling specifically in brain regions involved in reward and decision-making, including the prefrontal cortex and amygdala. The effect was specific to GABA-B receptors and did not spill over to other receptor types.²⁰ The molecular mechanism involves a protein called G-protein-coupled receptor kinase (GRK) binding to a subunit of the GABA-B receptor and dampening its response, a process known as desensitization.²¹

What this means in practice is that some patients find their original dose losing effectiveness over months or years. When tolerance develops, the clinical response is usually a cautious dose increase rather than an abrupt jump. For intrathecal pump patients, the titration guidelines described earlier apply. For oral users, clinicians sometimes edge above the 80 mg label, though this enters off-label territory and requires careful monitoring. Tolerance should not be confused with dependence, but the two often coexist: once your receptors have adjusted to baclofen’s presence, stopping the drug suddenly can provoke withdrawal.

Elderly Patients and Children

Age matters. A trial of baclofen in elderly stroke patients was abandoned because drowsiness was unacceptably severe, even though pharmacokinetic testing showed that the total drug exposure in elderly patients was similar to that of younger adults at the same dose. The elderly patients took longer to reach peak blood levels and cleared the drug more slowly, but the overall area under the curve was comparable. The investigators concluded that the increased drowsiness was probably not explained by pharmacokinetics alone, meaning the aging brain may simply be more sensitive to baclofen’s sedating effects.²² The practical implication: older adults typically need lower doses and slower titration, not because the drug builds up more but because the brain reacts more strongly.

Children with cerebral palsy are the largest pediatric group prescribed baclofen. A population pharmacokinetic study in children with cerebral palsy suggested that dosing can reasonably be based on body weight at about 2 mg per kilogram per day, and that the standard gradual dose-escalation approach works well for children older than two.²³ That weight-based guideline naturally produces lower absolute daily doses than adults receive, which makes sense given a child’s smaller body.

Mixing Baclofen with Alcohol and Other Sedatives

Baclofen is a central nervous system depressant, and combining it with other depressants amplifies that effect. A controlled study in heavy social drinkers found that baclofen combined with alcohol significantly increased sedation scores beyond what either substance produced alone.²⁴ This is particularly relevant because one of baclofen’s most discussed off-label uses is treating alcohol dependence, meaning patients taking it may still be drinking.

Animal research has shown that the baclofen-ethanol combination produces meaningful drops in blood oxygenation and causes progressive lung damage including swelling, fluid accumulation, and inflammatory cell infiltration that worsened over 24 hours.²⁵ While animal models do not translate directly to human outcomes, the direction of the findings is consistent with the clinical observation that respiratory depression is one of the most dangerous features of baclofen overdose, and alcohol lowers the threshold.

Benzodiazepines, opioids, and other sedating medications carry similar interaction risks. If you are prescribed baclofen and also take any of these, your prescriber should be aware and may need to adjust one or both drugs.

Other Uses at Lower Doses

Beyond spasticity and alcohol dependence, baclofen has shown up in clinical practice for a handful of other conditions at doses well within the standard range. Persistent hiccups are one of the more established niche uses. A case series documented several patients whose intractable hiccups resolved after a single 10 mg dose of baclofen, with some patients needing a short course of 10 mg three times daily before the hiccups stayed away.²⁶ Gastroesophageal reflux is another off-label area where baclofen is sometimes used at low doses to reduce transient relaxations of the lower esophageal sphincter. These applications rarely push the daily dose above 30 to 40 mg.

How Baclofen Compares to Other Muscle Relaxants

Baclofen is not the only option for spasticity. Tizanidine is its most common alternative, and the two have been compared head-to-head in several trials. A systematic review found fair evidence that both drugs are roughly equivalent in effectiveness for spasticity, particularly in multiple sclerosis. The key difference is the side-effect profile: baclofen tends to cause more muscle weakness, while tizanidine causes more dry mouth and drowsiness.²⁷

In a randomized crossover trial in MS patients, clinicians judged baclofen slightly superior on the combination of perceived efficacy and tolerability, though when patients rated the drugs themselves, the difference was not statistically significant. What did stand out was that muscle weakness was significantly more troublesome with baclofen, while somnolence and dry mouth were more common with tizanidine.²⁸ A broader review noted that improvement in muscle tone occurred in 60 to 65 percent of baclofen recipients, compared with 60 to 82 percent of tizanidine recipients and 60 to 83 percent of those taking diazepam. Tizanidine’s tolerability profile was generally rated more favorably.²⁹

Dantrolene is a third option that works differently, acting directly on skeletal muscle fibers rather than in the brain. It avoids the sedation problem but carries a risk of liver toxicity, especially at higher doses. The evidence comparing dantrolene directly to baclofen or tizanidine is thin, so the choice between them usually comes down to which side-effect trade-offs a patient can live with and whether sedation or weakness is the bigger concern for their daily life.